Page last updated: 2024-08-23

acetylgalactosamine and Parkinson Disease

acetylgalactosamine has been researched along with Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, Q; Ding, W; Li, S; Liu, J; Ma, L; Zhang, W1
Dowdy, SF; Springer, AD1

Reviews

1 review(s) available for acetylgalactosamine and Parkinson Disease

ArticleYear
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.
    Nucleic acid therapeutics, 2018, Volume: 28, Issue:3

    Topics: Acetylgalactosamine; Asialoglycoprotein Receptor; Clinical Trials as Topic; Endocytosis; Endosomes; Gene Transfer Techniques; Glycoconjugates; Hepatocytes; Liver; Nanoparticles; Neoplasms; Parkinson Disease; RNA, Small Interfering; Virus Diseases

2018

Other Studies

1 other study(ies) available for acetylgalactosamine and Parkinson Disease

ArticleYear
Identification of ADP/ATP Translocase 1 as a Novel Glycoprotein and Its Association with Parkinson's Disease.
    Neurochemical research, 2022, Volume: 47, Issue:11

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylgalactosamine; Adenine Nucleotide Translocator 1; Adenosine Diphosphate; Animals; Glycoproteins; Mice; Mitochondrial ADP, ATP Translocases; Parkinson Disease; Tandem Mass Spectrometry

2022